Update: Masks May Reduce SARS-CoV-2 Infection in Community Settings

2023-05-16
临床结果
TUESDAY, May 16, 2023 -- Masks may be associated with a small reduction in the risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in community settings, according to the final update of a living, rapid review published online May 16 in the Annals of Internal Medicine.
Roger Chou, M.D., and Tracy Dana, from Oregon Health & Science University in Portland, updated an evidence synthesis on N95, surgical, and cloth mask effectiveness for preventing SARS-CoV-2 infection in community and health care settings. Data were included from three randomized trials and 21 observational studies.
The researchers found that based on two randomized trials and seven observational studies, mask use may be associated with a small reduction in the risk for SARS-CoV-2 infection in community settings compared with no mask use. Surgical masks and N95 respirators may be associated with a similar risk for SARS-CoV-2 infection in routine patient care settings based on one new randomized trial with some imprecision and four observational studies. Due to methodological limitations and inconsistency, evidence from observational studies was insufficient to assess other mask comparisons.
"As in prior updates, our main finding for community settings was low-to-moderate strength evidence that mask use (any or unspecified type) may be associated with a small reduction in risk for SARS-CoV-2 infection versus no masks," the authors write.
Abstract/Full Text
Editorial
Posted May 2023
Further Support and Information on COVID-19
COVID-19: Prevention & Investigational Treatments
COVID-19 Support Group
Coronavirus Disease Guide
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。